Financial Gravity Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.33M Sell
47,971
-466
-1% -$71.4K 1.3% 21
2025
Q4
$6.68M Buy
48,437
+2,956
+6% +$387K 1.29% 23
2025
Q3
$5.83M Buy
+45,481
New +$5.55M 1.15% 23
2025
Q1
$4.58M Buy
+41,128
New +$4.38M 1% 25
2024
Q2
$4.16M Buy
39,067
+5,102
+15% +$512K 1.04% 23
2024
Q1
$3.43M Hold
33,965
0.96% 24
2023
Q4
$3.43M Buy
+33,965
New +$3.28M 0.96% 24
2021
Q3
Hold
0
407
2021
Q2
Hold
0
376
2020
Q4
$2K Buy
+19
New +$1.66K ﹤0.01% 331
2019
Q4
$95K Sell
65
-23
-26% -$2.06K 0.07% 340
2019
Q3
$8K Sell
88
-72
-45% -$6.46K 0.01% 637
2019
Q2
$15K Sell
160
-223
-58% -$18.9K 0.01% 517
2019
Q1
$33K Buy
+383
New +$30.7K 0.03% 376
2018
Q3
$14K Buy
185
+12
+7% +$887 0.01% 524
2018
Q2
$13K Buy
173
+2
+1% +$138 0.01% 528
2018
Q1
$12K Buy
+171
New +$13K 0.01% 566

Other funds holding NVS

Financial Gravity Asset Management's NVS Position: Q1 2026 in Review

Financial Gravity Asset Management reduced its Novartis (NVS) stake by 0.96% in Q1 2026, selling an estimated $71.4K and leaving 47,971 shares worth $7.33M. The position accounts for 1.3% of the portfolio, ranked #21.

Financial Gravity Asset Management first reported a position in NVS in Q1 2018 and has held it in 15 quarters since. 1,601 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Financial Gravity Asset Management held 47,971 shares of Novartis worth $7.33M as of Q1 2026.
  • Financial Gravity Asset Management sold 466 Novartis shares in Q1 2026, an estimated $71.4K.
  • Novartis made up 1.3% of Financial Gravity Asset Management's portfolio in Q1 2026, its #21 holding.
  • Financial Gravity Asset Management first reported a position in Novartis in Q1 2018 and has held it in 15 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.